Evidence map›Paper›PMID 39935210›Full record

SynthesisBrain and behavior2025

Effects of Repetitive Transcranial Magnetic Stimulation on Tumor Necrosis Factor Alpha in Neuropsychological Disorders: A Systematic Review and Meta-Analysis.

Arya Asadizeidabadi, Seyedmohammadamin Hosseini, Artem Pyatkov

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Computational Analysis andCurrent medicinal chemistry · 2026
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arya AsadizeidabadiUniversal Scientific Education and Research Network (USERN), Tehran, Iran.ORCID https://orcid.org/0009-0006-6669-6719
Seyedmohammadamin HosseiniSechenov University, Moscow, Russia.
Artem PyatkovDepartment of Functional Diagnostics, The Clinic of Nervous Diseases Named After. A.Ya. Kozhevnikov University Clinical Hospital No. 3, Moscow, Russia.ORCID https://orcid.org/0000-0001-7464-5205

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRepetitive transcranial magnetic stimulation (rTMS) shows promise in treating neuropsychological disorders. This systematic review and meta-analysis investigated the effects of rTMS on inflammatory cytokines and brain-derived neurotrophic factor (BDNF) under these conditions.

methodWe searched five electronic databases for relevant studies. Twelve studies (six randomized controlled trials [RCTs] and six cohort studies) were included in the systematic review, with six RCTs included in the meta-analysis. The primary outcome was tumor necrosis factor-alpha (TNF-α) levels, with secondary outcomes including interleukin-6 (IL-6), interleukin-1 beta (IL-1β), high-sensitivity C-reactive protein (hs-CRP), interferon-gamma (IFN-γ), and BDNF.

resultsMeta-analysis revealed a significant decrease in TNF-α levels after rTMS (weighted mean difference [WMD]: -6.65, 95% confidence interval [CI]: -10.47-2.83, p < 0.05), with greater effects associated with longer interventions. No significant change was found in the IL-6 levels. BDNF levels increased significantly (WMD: 7.97, 95% CI: 2.8-13.15, p < 0.05). Qualitative synthesis indicated consistent reductions in IL-1β. High heterogeneity was observed in some analyses.

conclusionrTMS may exert therapeutic effects on neuropsychological disorders partly through modulating neuroinflammation and promoting neuroplasticity. However, high heterogeneity and study limitations necessitate larger, more standardized clinical trials to confirm these effects and explore their clinical significance.

Indexed as

Transcranial Magnetic StimulationTumor Necrosis Factor-alphaBrain-Derived Neurotrophic FactorHumansBrain-Derived Neurotrophic FactorTumor Necrosis Factor-alphabrain‐derived neurotrophic factor (BDNF) | inflammatory cytokine | repetitive transcranial magnetic stimulator | tumor necrosis factor‐alpha (TNF‐α)

Identifiers

PMID39935210
PMCPMC11814483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.